Kengo Inagaki
Pediatric Infectious Diseases Ann Arbor, MI Medical Doctor
NPI 1144483694 CMS profile 1348041
1500 E Medical Center Dr, Ann Arbor, MI 48109
General payments
$6,949
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$36,243
Through program year 2025, Kengo Inagaki of Ann Arbor, MI is reported in the CMS Open Payments database as having received $6,949 across 6 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $36,243 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 79th percentile of Pediatric Infectious Diseases profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $6,949 | 6 |
Beside peers
- Kengo Inagaki
- Pediatric Infectious Diseases median
- Middle half of Pediatric Infectious Diseases
- National median
In program year 2025, general payments to Kengo Inagaki were reported at $6,949. Among 311 Pediatric Infectious Diseases profiles paid that year, the median was $126 and the middle half received between $41 and $2,094.
Show as a table
| Year | Kengo Inagaki | Pediatric Infectious Diseases median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $175 | $34–$2,175 | $163 |
| 2020 | $0 | $521 | $34–$6,009 | $114 |
| 2021 | $0 | $1,077 | $39–$4,557 | $132 |
| 2022 | $0 | $232 | $53–$6,196 | $149 |
| 2023 | $0 | $140 | $52–$4,662 | $160 |
| 2024 | $0 | $198 | $52–$3,860 | $164 |
| 2025 | $6,949 | $126 | $41–$2,094 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
6 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Infectious Diseases in Michigan
Jocelyn Ang
Pediatric Infectious Diseases · Detroit, MI
Michael Watson
Pediatric Infectious Diseases · Ann Arbor, MI
John Lipuma
Pediatric Infectious Diseases · Ann Arbor, MI
Kay Leopold
Pediatric Infectious Diseases · Ann Arbor, MI
Basim Asmar
Pediatric Infectious Diseases · Detroit, MI
Nahed Abdel-Haq
Pediatric Infectious Diseases · Detroit, MI
Related records
Pediatric Infectious Diseases in Michigan
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Infectious Diseases
Everyone recorded under this specialty, nationwide.
Doctors in Michigan
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.